NL8200022A - Farmaceutische samenstelling, die gamma-butyrobetaine bevat, voor de behandeling van door l-carnitine gebrek teweeggebrachte syndromen. - Google Patents

Farmaceutische samenstelling, die gamma-butyrobetaine bevat, voor de behandeling van door l-carnitine gebrek teweeggebrachte syndromen. Download PDF

Info

Publication number
NL8200022A
NL8200022A NL8200022A NL8200022A NL8200022A NL 8200022 A NL8200022 A NL 8200022A NL 8200022 A NL8200022 A NL 8200022A NL 8200022 A NL8200022 A NL 8200022A NL 8200022 A NL8200022 A NL 8200022A
Authority
NL
Netherlands
Prior art keywords
carnitine
butyrobetaine
gamma
patients
treatment
Prior art date
Application number
NL8200022A
Other languages
English (en)
Dutch (nl)
Inventor
Claudio Cavazza
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Publication of NL8200022A publication Critical patent/NL8200022A/nl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NL8200022A 1981-01-06 1982-01-06 Farmaceutische samenstelling, die gamma-butyrobetaine bevat, voor de behandeling van door l-carnitine gebrek teweeggebrachte syndromen. NL8200022A (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT4751881 1981-01-06
IT47518/81A IT1198434B (it) 1981-01-06 1981-01-06 Composizione farmaceutica comprendente gamma butirrobetaina per il trattamento di sindromi da carenze di carnitina

Publications (1)

Publication Number Publication Date
NL8200022A true NL8200022A (nl) 1982-08-02

Family

ID=11260827

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8200022A NL8200022A (nl) 1981-01-06 1982-01-06 Farmaceutische samenstelling, die gamma-butyrobetaine bevat, voor de behandeling van door l-carnitine gebrek teweeggebrachte syndromen.

Country Status (15)

Country Link
US (1) US4382092A (it)
JP (1) JPS57136516A (it)
AU (1) AU548787B2 (it)
BE (1) BE891639A (it)
CH (1) CH649218A5 (it)
DE (1) DE3200016A1 (it)
FR (1) FR2497510B1 (it)
GB (1) GB2091101B (it)
GR (1) GR75132B (it)
IE (1) IE52404B1 (it)
IL (1) IL64632A0 (it)
IT (1) IT1198434B (it)
LU (1) LU83869A1 (it)
NL (1) NL8200022A (it)
SE (1) SE453569B (it)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1190280B (it) * 1986-04-24 1988-02-16 Sigma Tau Ind Farmaceuti Procedimento per la preparazione di gamma-butirrobetaina
US5030458A (en) * 1989-11-27 1991-07-09 Shug Austin L Method for preventing diet-induced carnitine deficiency in domesticated dogs and cats
IT1219448B (it) * 1988-02-12 1990-05-18 Sigma Tau Ind Farmaceuti Alimento per animali domestici carnivori, in particolare per cani integrato con l-carnitina
US5240961A (en) * 1992-07-02 1993-08-31 Shug Austin L Method of treating reduced insulin-like growth factor and bone loss associated with aging
US20030170290A1 (en) * 1993-06-16 2003-09-11 Shug Austin L. Delayed release carnitine
JP2553013B2 (ja) * 1993-07-19 1996-11-13 ヤマハ発動機株式会社 燃料噴射式エンジンの吸気装置
US5569457A (en) * 1994-11-18 1996-10-29 Shug; Austin L. Method of stimulating antibody formation
JP3119430B2 (ja) * 1995-07-25 2000-12-18 大鵬薬品工業株式会社 水酸基ラジカル消去剤
LV11727B (en) * 1995-08-21 1997-08-20 Kalvins Ivars Pharmaceutical composition
LV11728B (en) * 1995-08-21 1997-08-20 Kalvins Ivars Pharmaceutical composition
AUPO821097A0 (en) * 1997-07-25 1997-08-14 Cultor Ltd. A prophylactic
KR100411275B1 (ko) * 1999-09-15 2003-12-18 주식회사 포스코 언로더 코일 적치위치 제어장치
DE19956772A1 (de) * 1999-11-25 2001-06-07 Basf Ag Verwendung von y-Butyrobetain Salzen zur Herstellung von Zubereitungen für die menschliche und tierische Ernährung
US6476010B2 (en) 2000-03-10 2002-11-05 Hill's Pet Nutrition Method for increasing intestinal absorption of fat soluble vitamins in post-menopausal women and lower animals
LV12979B (en) * 2001-09-07 2003-05-20 Ivars Kalvins Pharmaceutical composition
LV12978B (en) * 2001-09-07 2003-05-20 Ivars Kalvins Pharmaceutical composition

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4346107A (en) * 1979-02-12 1982-08-24 Claudio Cavazza Pharmaceutical composition comprising acyl-carnitine for the treatment of impaired cerebral metabolism

Also Published As

Publication number Publication date
DE3200016C2 (it) 1992-12-03
JPS57136516A (en) 1982-08-23
US4382092A (en) 1983-05-03
LU83869A1 (fr) 1982-05-07
CH649218A5 (it) 1985-05-15
AU548787B2 (en) 1986-01-02
FR2497510B1 (fr) 1986-04-25
SE453569B (sv) 1988-02-15
GB2091101B (en) 1985-02-20
GB2091101A (en) 1982-07-28
IT1198434B (it) 1988-12-21
FR2497510A1 (fr) 1982-07-09
IL64632A0 (en) 1982-03-31
DE3200016A1 (de) 1982-08-12
JPH0424325B2 (it) 1992-04-24
IE52404B1 (en) 1987-10-14
GR75132B (it) 1984-07-13
SE8200007L (sv) 1982-07-07
AU7908781A (en) 1982-07-15
IE813099L (en) 1982-07-06
IT8147518A0 (it) 1981-01-06
BE891639A (fr) 1982-04-16

Similar Documents

Publication Publication Date Title
US10111849B2 (en) Use of medium chain triglycerides for the treatment and prevention of Alzheimer's disease and other diseases resulting from reduced neuronal metabolism II
NL8200022A (nl) Farmaceutische samenstelling, die gamma-butyrobetaine bevat, voor de behandeling van door l-carnitine gebrek teweeggebrachte syndromen.
US4255449A (en) Method of treating abnormal lipoprote in ratios
JPH027572B2 (it)
CN1679532A (zh) 治疗和饮食组合物
EP0336851A1 (fr) Composition pharmaceutique pour administration orale à base d'un dérivé d'acide diphosphonique
US5645852A (en) Butyric ester cyto-differtiating agents
US7666909B2 (en) Enhancement of alcohol metabolism
WO1991007960A1 (fr) Compositions pharmaceutiques destinees au traitement de l'ataxie et les troubles de l'equilibre
RU2636616C1 (ru) Комбинированное лекарственное средство для первичной нейропротекции
SK287832B6 (sk) Use of acetyl L-carnitine in association with biotin for the treatment of patients with Type 2 insulin-resistant diabetes mellitus.
EP3804705A1 (en) Pharmaceutical composition for preventing diabetes and use thereof
RU2387448C2 (ru) Незаменимые жирные кислоты, предназначенные для предупреждения и/или лечения депрессии у пациентов, страдающих коронарной болезнью сердца или болезнью коронарной артерии
KR100725263B1 (ko) ＨＭＧ-ＣｏＡ 리덕타제 억제제 및 카르니틴을 포함하는 항지질혈성 복합제
BE1030299B1 (fr) Application de la 5'-méthylthioadénosine dans la préparation de médicaments ou de produits de santé anti-obésité
RU2095059C1 (ru) Способ профилактики и лечения атеросклероза
WO2003009840A1 (en) Composition comprising at least one lipase inhibitor and carnitine
JP4896531B2 (ja) 血中ＣｏＱ１０量を増加させる医薬組成物
WO2023156275A1 (en) Pharmaceutical composition and medicament comprising l-tryptophan, l-5-hydroxytryptophan and a peripheral degradation inhibitor
JPH03115220A (ja) 非心臓由来の不整脈防止薬
TW201300119A (zh) 用於治療脂質代謝失調之組成物

Legal Events

Date Code Title Description
A85 Still pending on 85-01-01
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
BV The patent application has lapsed